Biology · 2026
Anxiolytic and Anticonvulsant Effects of Moringa Isothiocyanate-1 (MIC-1) in Adult Zebrafish.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Martins João Victor Alves, da Cruz Freire José Ednésio, Correia de Oliveira Maria Rayane, Alves do Nascimento Gabriela, Sabóia Lia Gomes Crisóstomo, Coelho Paulo Adenes Teixeira, Lima Lorena Silva, Alves de Oliveira Keciany, Batista Francisco Lucas Alves, Ishiki Hamilton Mitsugu, Vieira-Neto Antonio Eufrásio, Santos Sacha Aubrey Alves Rodrigues, Campos Adriana Rolim, Frota Lucas Soares, Morais Selene Maia de, Farias-Pereira Renalison, Magalhães Francisco Ernani Alves, Oliveira Ariclécio Cunha de
Аннотация
The 'miracle tree' Moringa oleifera from the Moringaceae family is recognized for its rich nutritional value and therapeutic properties. This study aimed to evaluate the phytopharmaceutical compound Moringa isothiocyanate-1 (MIC-1) isolated from hydroalcoholic extract of M. oleifera seeds for the treatment of seizures and anxiety in adult zebrafish. MIC-1 (up to 0.5 mg/mL) did not show any acute toxic effects over a 96-h period. Moreover, MIC-1 (0.005 and 0.05 mg/mL) delayed the onset of seizures induced by pentylenetetrazol, indicating anticonvulsant activity. The anticonvulsant effects of MIC-1 (0.05 mg/mL) were reversed by flumazenil, suggesting a mechanism involving the GABAA receptor. Furthermore, MIC-1 (0.05 mg/mL) has anxiolytic effects, with involvement of the serotonergic and GABAergic systems. In silico assays confirmed the interaction of MIC-1 with the GABAA, 5-HT1B, 5-HT2A/C, and 5-HT3A/B receptors. Additionally, MIC-1 was effective in treating anxiety related to alcohol withdrawal in zebrafish. These findings suggest the pharmacological potential of MIC-1 for the development of new treatments for seizures and anxiety.